SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%
Thu, 30 May

SUN PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m69,77177,40271,639-7.4%2.7%
Other incomeRs m3,0281,9312,81545.8%-7.0%
TurnoverRs m72,79979,33374,455-6.1%2.3%
ExpensesRs m52,93655,87361,47110.0%16.1%
Gross profitRs m16,83521,52910,168-52.8%-39.6%
DepreciationRs m4,5524,7114,541-3.6%-0.3%
InterestRs m1,5541,4481,5003.6%-3.4%
Profit before taxRs m13,75617,3016,942-59.9%-49.5%
TaxRs m-1,7672,709-288-110.6%
Profit after taxRs m15,52314,5927,231-50.4%-53.4%
Gross profit margin%24.127.814.2
Effective tax rate%-12.815.7-4.1
Net profit margin%21.318.49.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 2.7% on a year-on-year (YoY) basis. The expenses were up by 16.1% YoY during the same period.
  • The company's operating profit declined by 39.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 24.1% in 4QFY18.
  • Depreciation charges declined by 0.3% and finance costs declined by 3.4% YoY, respectively.
  • Other income declined by 7.0% YoY during the quarter.
  • Net profit for the quarter declined by 53.4% YoY. Net profit margins during the quarter declined from 21.3% in 4QFY18 to 9.7% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 7.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 10.0% QoQ during the same period.
  • The company's operating profit declined by 52.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 27.8% in 3QFY18.
  • Net profit for the quarter declined by 50.4% QoQ, while net profit margins declined from 18.4% in 3QFY18 to 9.7% in 4QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 494.8 to Rs 418.3, registering a Loss of Rs 76.5 or around 15.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,333.1 (up 0.2%). Over the last one year it has moved up from 13,111.9 to 13,333.1, a gain of 221 points (up 1.7%).

Overall, the S&P BSE SENSEX is up 13.6% over the year.

Current Valuations

At the current price of Rs 418.3, the price to earnings (P/E) ratio of SUN PHARMA stands at 31.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.6 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 10, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS